Owlet, Inc. (OWLT) Stock Price & How to Invest

Last updated November 2026

Short answer

Owlet makes the Dream Sock, an FDA-authorized baby monitor that tracks an infant's heart rate and oxygen level, plus cameras and a paid Owlet360 app. At $2.96 on November 20, 2026 the stock is worth ~$88 million, under 0.8x sales and down ~82% year to date, after a camera cable safety update wiped out 2026 guidance. It is a small, cheap, event-driven name where the next two quarters matter most.

OWLT stock price

As of 2026-11-20, Owlet, Inc. (OWLT) last closed at $2.93, down 75.4% over the past year. Over the past 52 weeks it has traded between $2.93 and $16.52.

OWLT last close
$2.93
1 day
-9.29%
1 month
-30.24%
1 year
-75.38%
52-week range
$2.93 to $16.52
Last close
2026-11-20

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Owlet, Inc.'s investor relations page. Walnut is informational, not investment advice.

OWLT key stats

At $2.93 on November 20, 2026, Owlet, Inc. (OWLT) has a market cap of $88M.

Market cap
$88M
P/E (forward)
14.3
Price to book
3.2
Beta
2.22

Market cap, P/E and yield are measured at the $2.93 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Owlet, Inc. (OWLT)?

The last two weeks for Owlet, Inc., as of November 22, 2026: the price move, the next earnings date, and what analysts changed.

  • OWLT closed at $2.93 on November 20, 2026, down 14.8% over the past five trading days (from $3.44).
  • On November 16, 2026, TD Cowen lowered its target to $4.00 from $10.00 (Buy).

Prices are daily closes from Yahoo Finance. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

What does Owlet, Inc. (OWLT) do?

Owlet, Inc. is a Lehi, Utah company that sells connected baby monitoring products. Its flagship is the Dream Sock, a fabric sock with a sensor that reads an infant's pulse rate and oxygen saturation and sends notifications to a parent's phone; it received FDA De Novo authorization in 2023 as an over-the-counter device. Owlet also sells the Dream Sight camera, the Dream Duo bundle of sock plus camera, and BabySat, a prescription version of the sock. A growing share of revenue now comes from Owlet360, a monthly subscription for sleep history, trends and insights. The company went public in 2021 by merging with the Sandbridge SPAC.

The third quarter of 2026, reported November 13, was solid on its own terms. Revenue was ~$30.4 million, down ~5% from ~$32.0 million a year earlier, because hardware fell ~12% to ~$26.8 million. Subscription revenue more than doubled to ~$3.6 million from ~$1.5 million, on more than 142,000 paying subscribers, with a ~68% gross margin. Total gross margin rose to ~53.8%, operating income was ~$1.2 million and net income was ~$1.4 million. Cash was ~$31.6 million at quarter end. For nine months, revenue was ~$86.7 million, up from ~$79.6 million, and the net loss shrank to ~$2.4 million from ~$29.7 million.

The same release changed the picture. After a reported incident involving exposed camera cables, Owlet issued a safety update to every camera owner, began shipping an enclosed replacement cable guard free on request, and stopped selling Dream Sight and Dream Duo units without the new guard. It withdrew its full-year 2026 outlook and, per its 10-Q and coverage of the call, estimated a ~$13 to $18 million hit, mostly in Q4, from retailer returns, rework and support costs, with some insurance coverage possible but not booked. The stock fell from ~$4.62 to under $3 on the day and closed at $2.96 on November 20, down ~82% year to date and ~75% over twelve months, against a 52-week high of ~$16.94. At that price the market value is ~$88 million on ~29.9 million shares, roughly 0.78x trailing sales of ~$113 million. Three days before the report, on November 10, Owlet launched a smart thermometer, its first product for everyday family health outside sleep monitoring.

What's driving Owlet, Inc. (OWLT)?

1. Owlet360 subscriptions

Subscriptions are the part of Owlet that is growing fastest and carrying the best margins. Revenue from Owlet360 was ~$3.6 million in Q3 2026, up ~137% from ~$1.5 million a year earlier, and ~$9.5 million for the first nine months against ~$2.8 million in the same stretch of 2025. Paying subscribers passed 142,000. Subscription gross margin was ~68%, well above the hardware business, and the segment is now ~12% of revenue. Each sock sold is a chance to sign up a paying user for the months a baby is being monitored. If attach rates hold while hardware sales are disrupted, this line cushions the blow; if new camera and sock sales stall, the subscriber funnel narrows with them.

2. Resolving the camera safety update

The single largest near-term variable is how fast the camera issue clears. Owlet began shipping an enclosed cable guard free to camera owners on request from November 13, 2026, and stopped selling Dream Sight and Dream Duo units that lack it. The company described the step as a safety update and action request, not a recall. It put the expected net impact at ~$13 to $18 million, mostly in Q4 2026, with cash effects possibly running into the first half of 2027, and said insurance could cover up to ~$10 million of certain costs, with no recovery recorded yet. Against a quarter of ~$30 million revenue, the size of that range and the speed at which retailers restock decide what 2027 looks like.

3. FDA authorization as a moat

Owlet's position rests on regulatory clearance most rivals lack. The Dream Sock holds FDA De Novo authorization as an over-the-counter device that shows an infant's pulse rate and oxygen level, and BabySat is cleared for prescription use. That matters more after Amazon set an August 10, 2026 deadline requiring FDA clearance for listings of this kind; Owlet's Q3 release noted competitors discounted heavily ahead of it. Fewer uncleared sock and wearable monitors on the largest retail channel could make Owlet's share easier to defend in 2027. The flip side is that the advantage depends on keeping regulators and parents confident in the brand, which the camera incident tests directly.

4. Margins and the balance sheet

Before the safety update, Owlet had moved close to self-funding. Gross margin reached ~53.8% in Q3 2026, up ~3 points from a year earlier, and adjusted EBITDA was ~$3.5 million versus ~$1.6 million. Nine-month operating cash burn was only ~$3.0 million. In June 2026 the company replaced its old term loan with a Wells Fargo asset-based revolver of up to ~$25 million, and it reported repaying the ~$11 million drawn on that line in October. Cash was ~$31.6 million at September 30. That cushion is about equal to the low end of the estimated remediation hit, which leaves limited room if Q4 and early 2027 come in weaker than management expects or retailers keep inventory low.

What are the risks to Owlet, Inc. (OWLT)?

The camera safety update is the immediate risk. Owlet's own range of ~$13 to $18 million in costs is an estimate, insurance recovery is uncertain, and it has not said when Dream Sight and Dream Duo sales return to normal at retailers. A safety issue on a baby product also invites regulatory attention and possible product liability claims, and Owlet has been here before: a 2021 FDA warning letter forced it to pull the original Smart Sock from the US market. Customer concentration is high, with one customer at ~38% of Q3 revenue and the top three at ~65% of receivables, so one retailer's decisions can move a quarter. Hardware revenue already fell ~12% in Q3 before the stop sale. The birth rate in the US and other markets is flat to falling, which caps the pool of new parents. The balance sheet holds ~$31.6 million of cash, about equal to the cost estimate, and there are convertible preferred shares and warrants that could dilute common holders. With guidance withdrawn and a market value near ~$88 million, the stock can swing sharply on small news, as the move from ~$16.94 to ~$2.75 over the past year shows.

What is the Owlet, Inc. (OWLT) forecast?

4 analysts publish price targets on OWLT, averaging $9.00 as of November 2026, or +207.2% against the $2.93 share price on November 20, 2026. The published targets run from $4.00 to $14.00, a wide spread, and the ratings split 5 buy, 0 hold, 0 sell. Over the last six months there have been 0 raises and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full OWLT forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

Is OWLT a buy or a sell?

We give no verdict on Owlet, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Owlet360 subscriptions. Subscriptions are the part of Owlet that is growing fastest and carrying the best margins. The most optimistic published target, $14.00, assumes this works close to its best case.

The case against. The camera safety update is the immediate risk. The most pessimistic target, $4.00, is roughly what OWLT is worth if this bites instead.

Read the full bull and bear case on OWLT, including what would have to change to break either one. Walnut is not an investment adviser.

How is Owlet, Inc. (OWLT) valued?

Market cap, P/E and dividend yield at today's price are in the OWLT key stats above. The business figures below come from Owlet, Inc.'s reported results as of November 2026 and change when it next reports.

  • Revenue (TTM): ~$113 million
  • Net income (TTM): ~-$14.6 million
  • Cash (Sept 30, 2026): ~$31.6 million
  • Q3 2026 gross margin: ~53.8%

As of November 2026: Owlet has no meaningful P/E: the trailing net loss of ~$14.6 million includes earlier, weaker quarters, while Q3 2026 alone was slightly profitable. On sales, ~0.78x trailing revenue of ~$113 million is low for a company with a ~54% gross margin and a fast-growing subscription line. Netting out ~$31.6 million of cash (the revolver was reported repaid in October) gives an enterprise value near ~$57 million, about 0.5x sales. Analysts covering it on Yahoo Finance carry an average target near ~$9, though several cut targets after the update (TD Cowen to $4, Northland to $7).

Who competes with Owlet, Inc. (OWLT)?

Smart video monitor makers

Nanit, Cubo AI and Miku sell camera-based monitors that track sleep and breathing motion through video analytics and pair them with subscriptions. They compete head to head with Owlet's Dream Sight camera and Owlet360, and the camera safety update gives them an opening at retailers while Owlet's camera stock is held back.

Wearable and sock monitors

Wearable and clip-on movement monitors from brands such as Snuza and Sense-U, along with other sock-style trackers, target the same parents who want readings from the baby's body. Most lack FDA authorization for oxygen and pulse readings, which limits what they can claim and, since Amazon's August 2026 clearance deadline, where they can be listed.

Mass-market baby monitor brands

VTech, Motorola-branded monitors, Infant Optics and similar brands sell basic audio and video monitors at lower prices through big-box stores and Amazon. They do not offer vitals readings, but they set the price anchor that makes a premium sock-plus-camera bundle a harder sell for budget-minded parents.

What stocks are similar to Owlet, Inc. (OWLT)?

Other names that sit close to OWLT: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

How to invest in Owlet, Inc. (OWLT)

There are three common ways to get OWLT exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so OWLT sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where OWLT fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

The bottom line on Owlet, Inc. (OWLT)

Owlet has a real, growing subscription business and a near-breakeven P&L, but the November 2026 camera safety update reset the story. At $2.96 on November 20, 2026, down ~28% in a month and ~75% over a year, the price reflects heavy doubt about the recovery.

More on Owlet, Inc. (OWLT)

Whether OWLT is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is OWLT a buy or a sell?, and where the stock could go from here in the OWLT stock forecast.

For income investors, whether OWLT pays a dividend and how the payout looks is covered in does OWLT pay a dividend? And to weigh OWLT against a peer, read the full side-by-side comparisons: OWLT vs AMZN and OWLT vs MSI.

Wondering how OWLT fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Owlet, Inc.

Ask Walnut's AI anything about OWLT and see how it fits what you own.

FAQ

What does Owlet do?

+

Owlet sells connected products for monitoring babies while they sleep. The Dream Sock wraps around an infant's foot and reads pulse rate and oxygen saturation, sending readings and notifications to a parent's phone. It received FDA De Novo authorization in 2023 for over-the-counter use. Owlet also sells the Dream Sight camera, the Dream Duo bundle of sock and camera, and BabySat, a version for prescription use. In November 2026 it added a smart thermometer, its first everyday family health product. On top of the hardware sits Owlet360, a paid subscription that stores sleep history and adds trends and insights; it had more than 142,000 paying subscribers at the end of Q3 2026. The company is based in Lehi, Utah, sells mostly through large retailers and its own site, and listed on the NYSE in 2021 through a merger with the Sandbridge Acquisition SPAC.

Why did OWLT stock fall in November 2026?

+

The drop came with the Q3 2026 report on November 13. Alongside decent results, Owlet disclosed a safety incident involving exposed camera cables, told every camera owner to take certain safety steps, began shipping an enclosed replacement cable guard free on request, and stopped selling Dream Sight and Dream Duo units without the new guard. It also withdrew its full-year 2026 outlook, citing remediation costs, a Q4 retail sales interruption, retailer returns and demand uncertainty. Coverage of the filings put the expected net impact at ~$13 to $18 million, mostly in Q4. The stock fell from a ~$4.62 prior close to under $3 that day, and analysts including TD Cowen, Northland and Lake Street cut their targets. It closed at $2.96 on November 20, 2026, ~28% lower than a month earlier.

Is the Owlet camera issue a recall?

+

Owlet calls it a safety update and action request, not a recall. The Q3 release says the company received a safety incident report involving exposed camera cables and asked all camera owners to take certain safety measures. From November 13, 2026, it began shipping an enclosed cable guard system free of charge to any camera owner who requests one, and its 10-Q refers to a stop sale on units without that guard. The issue concerns the camera's cable guard accessory, not the Dream Sock's sensor. Whether regulators treat it differently, and whether it leads to product liability claims, is not yet known. Parents with an Owlet camera can find the instructions and the replacement request on Owlet's own support pages.

How much revenue does Owlet make?

+

Owlet's trailing twelve-month revenue is ~$113 million as of November 2026. Full-year 2025 revenue was ~$105.7 million, up ~35% from 2024, helped by the Dream Sock's FDA authorization and new retail placement. In the first nine months of 2026, revenue reached ~$86.7 million against ~$79.6 million a year earlier. Q3 2026 revenue was ~$30.4 million, down ~5% year over year, as hardware fell ~12% to ~$26.8 million while subscription revenue rose ~137% to ~$3.6 million. Subscriptions are still only about an eighth of the total, so the business remains mostly a hardware seller. Q4 2026 revenue is expected to be hit by the camera stop sale and retailer returns, and Owlet has not given a new number.

Is Owlet profitable?

+

Owlet is near breakeven at the quarterly level but not profitable over the last year. Q3 2026 produced ~$1.2 million of operating income, ~$1.4 million of net income and ~$3.5 million of adjusted EBITDA, which excludes ~$2.6 million of stock-based compensation. The nine-month net loss was ~$2.4 million, much smaller than ~$29.7 million a year earlier. Over the trailing twelve months, the net loss is ~$14.6 million, or ~-$0.55 per share on Yahoo Finance's basis, which includes weaker earlier quarters and non-cash items such as warrant and debt-extinguishment charges. The camera safety update is expected to push Q4 2026 into a loss, so a full year of profit has moved further out.

What is Owlet's valuation at ~$3.23?

+

At ~$3.23 a share (the November 19 close) Owlet's market value was ~$97 million; at the November 20, 2026 close of $2.96 and ~29.9 million common shares outstanding, it is ~$88 million. That is ~0.78x trailing revenue of ~$113 million. Subtracting ~$31.6 million of cash at September 30, 2026 (Owlet reported repaying its ~$11 million revolver balance in October), the enterprise value is roughly ~$57 million, or ~0.5x sales. There is no meaningful P/E because the trailing net result is a loss. The stock traded as high as ~$16.94 within the last 52 weeks and as low as ~$2.75. The four analysts in Yahoo Finance's count carry an average target near ~$9, a figure that blends targets set before and after the November cuts, so the spread between them is wide.

Who are Owlet's main competitors?

+

Owlet competes on three fronts. Smart video monitors such as Nanit, Cubo AI and Miku track breathing motion and sleep through a camera and sell their own subscriptions, competing with Dream Sight and Owlet360. Wearable monitors such as the movement sensors from Snuza and Sense-U go after parents who want readings from the baby's body, though most do not hold FDA authorization for oxygen and pulse readings. Mass-market brands like VTech, Motorola-branded monitors and Infant Optics sell basic audio and video monitors at lower prices. Owlet's FDA authorization is its main point of difference, and Amazon's August 2026 deadline requiring clearance for such listings reduced the number of uncleared rivals on that channel.

What are the biggest risks for Owlet?

+

The first is the camera safety update: the cost estimate of ~$13 to $18 million is close to the company's ~$31.6 million cash balance, insurance recovery is uncertain, and the timing of a full return to retail shelves is unknown. The second is concentration, with one customer at ~38% of Q3 2026 revenue. The third is regulatory: as a company selling medical-grade monitoring for infants, Owlet depends on FDA authorization and parent trust, and it already lost its original Smart Sock in the US after a 2021 FDA warning letter. Hardware sales were falling before the stop sale, falling birth rates limit the market, and convertible preferred stock and warrants could dilute common shareholders. The stock is small and volatile.

How has OWLT stock performed in 2026?

+

OWLT closed at $2.96 on November 20, 2026, down ~82% year to date and ~75% over the past year, near the bottom of its 52-week range of ~$2.75 to ~$16.94. The shares fell ~43% over three months and ~28% in the latest month, most of it on November 13 when the camera safety update and the withdrawn 2026 outlook came out with third-quarter results. Q3 EPS of $0.11 beat a consensus near breakeven, which did not stop the decline.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Owlet, Inc.'s investor relations page or your broker before making investment decisions.